170 related articles for article (PubMed ID: 24091029)
1. EGFR and microvessel density in canine malignant mammary tumours.
Carvalho MI; Guimarães MJ; Pires I; Prada J; Silva-Carvalho R; Lopes C; Queiroga FL
Res Vet Sci; 2013 Dec; 95(3):1094-9. PubMed ID: 24091029
[TBL] [Abstract][Full Text] [Related]
2. COX-2 over-expression correlates with VEGF and tumour angiogenesis in canine mammary cancer.
Queiroga FL; Pires I; Parente M; Gregório H; Lopes CS
Vet J; 2011 Jul; 189(1):77-82. PubMed ID: 20675158
[TBL] [Abstract][Full Text] [Related]
3. Concurrent expression of cyclo-oxygenase-2 and epidermal growth factor receptor in canine malignant mammary tumours.
Guimarães MJ; Carvalho MI; Pires I; Prada J; Gil AG; Lopes C; Queiroga FL
J Comp Pathol; 2014 Jan; 150(1):27-34. PubMed ID: 24060154
[TBL] [Abstract][Full Text] [Related]
4. Different role of COX-2 and angiogenesis in canine inflammatory and non-inflammatory mammary cancer.
Clemente M; Sánchez-Archidona AR; Sardón D; Díez L; Martín-Ruiz A; Caceres S; Sassi F; Dolores Pérez-Alenza M; Illera JC; Dunner S; Peña L
Vet J; 2013 Aug; 197(2):427-32. PubMed ID: 23489848
[TBL] [Abstract][Full Text] [Related]
5. Tumour-associated macrophages are associated with vascular endothelial growth factor expression in canine mammary tumours.
Raposo TP; Pires I; Carvalho MI; Prada J; Argyle DJ; Queiroga FL
Vet Comp Oncol; 2015 Dec; 13(4):464-74. PubMed ID: 24119241
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues.
Gama A; Gärtner F; Alves A; Schmitt F
Res Vet Sci; 2009 Dec; 87(3):432-7. PubMed ID: 19464036
[TBL] [Abstract][Full Text] [Related]
7. Cox-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival.
Lavalle GE; Bertagnolli AC; Tavares WL; Cassali GD
Vet Pathol; 2009 Nov; 46(6):1275-80. PubMed ID: 19605908
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral FoxP3 expression is associated with angiogenesis and prognosis in malignant canine mammary tumors.
Carvalho MI; Pires I; Prada J; Gregório H; Lobo L; Queiroga FL
Vet Immunol Immunopathol; 2016 Oct; 178():1-9. PubMed ID: 27496736
[TBL] [Abstract][Full Text] [Related]
9. Positive Interplay Between CD3+ T-lymphocytes and Concurrent COX-2/EGFR Expression in Canine Malignant Mammary Tumors.
Carvalho MI; Pires I; Prada J; Ferreira AF; Queiroga FL
Anticancer Res; 2015 May; 35(5):2915-20. PubMed ID: 25964576
[TBL] [Abstract][Full Text] [Related]
10. Quantification of epidermal growth factor receptor (EGFR) in canine mammary tumours by ELISA assay: clinical and prognostic implications.
Queiroga FL; Perez-Alenza MD; González-Gil A; Silván G; Peña L; Illera JC
Vet Comp Oncol; 2017 Jun; 15(2):383-390. PubMed ID: 26463704
[TBL] [Abstract][Full Text] [Related]
11. Tryptase-positive mast cells correlate with angiogenesis in canine mammary carcinoma.
Im KS; Kim JH; Yhee JY; Yu CH; Kim NH; Nho WG; Sur JH
J Comp Pathol; 2011; 144(2-3):157-63. PubMed ID: 20934709
[TBL] [Abstract][Full Text] [Related]
12. Expression of NOS and VEGF in feline mammary tumours and their correlation with angiogenesis.
Islam MS; Matsumoto M; Hidaka R; Miyoshi N; Yasuda N
Vet J; 2012 Jun; 192(3):338-44. PubMed ID: 22154426
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of microvessel density (MVD) in canine mammary tumours by quantitative immunohistochemistry of the claudin-5 molecule.
Jakab C; Halász J; Kiss A; Schaff Z; Szász AM; Rusvai M; Tóth ZA; Kulka J
Acta Vet Hung; 2008 Dec; 56(4):495-510. PubMed ID: 19149104
[TBL] [Abstract][Full Text] [Related]
14. High COX-2 expression is associated with increased angiogenesis, proliferation and tumoural inflammatory infiltrate in canine malignant mammary tumours: a multivariate survival study.
Carvalho MI; Pires I; Prada J; Raposo TP; Gregório H; Lobo L; Queiroga FL
Vet Comp Oncol; 2017 Jun; 15(2):619-631. PubMed ID: 26792550
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of angiogenesis in canine mammary tumors by quantitative platelet endothelial cell adhesion molecule immunohistochemistry.
Restucci B; De Vico G; Maiolino P
Vet Pathol; 2000 Jul; 37(4):297-301. PubMed ID: 10896390
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of vascular endothelial growth factor in canine mammary tumours.
Santos AA; Oliveira JT; Lopes CC; Amorim IF; Vicente CM; Gärtner FR; Matos AJ
J Comp Pathol; 2010 Nov; 143(4):268-75. PubMed ID: 20570280
[TBL] [Abstract][Full Text] [Related]
17. Canine mammary carcinomas: influence of histological grade, vascular invasion, proliferation, microvessel density and VEGFR2 expression on lymph node status and survival time.
Diessler ME; Castellano MC; Portiansky EL; Burns S; Idiart JR
Vet Comp Oncol; 2017 Jun; 15(2):450-461. PubMed ID: 26833549
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of tumour-associated macrophages in canine mammary tumours.
Raposo T; Gregório H; Pires I; Prada J; Queiroga FL
Vet Comp Oncol; 2014 Mar; 12(1):10-9. PubMed ID: 22533625
[TBL] [Abstract][Full Text] [Related]
19. Sialylation regulates galectin-3/ligand interplay during mammary tumour progression--a case of targeted uncloaking.
de Oliveira JT; de Matos AJ; Santos AL; Pinto R; Gomes J; Hespanhol V; Chammas R; Manninen A; Bernardes ES; Albuquerque Reis C; Rutteman G; Gärtner F
Int J Dev Biol; 2011; 55(7-9):823-34. PubMed ID: 22161838
[TBL] [Abstract][Full Text] [Related]
20. Expression of vascular endothelial growth factor in canine inflammatory and non-inflammatory mammary carcinoma.
Millanta F; Caneschi V; Ressel L; Citi S; Poli A
J Comp Pathol; 2010 Jan; 142(1):36-42. PubMed ID: 19632688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
